X-34 Labeling of Abnormal Protein Aggregates During the Progression of Alzheimer's Disease

Methods in Enzymology

Volumn 412, Issue , 2006, Pages 123-144

  Ikonomovic, Milos D ^a   Abrahamson, Eric E ^a   Isanski, Barbara A ^a   Debnath, Manik L ^a   Mathis, Chester A ^a   DeKosky, Steven T ^a   Klunk, William E ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; CONGO RED; DYE; PRESENILIN 1; UNCLASSIFIED DRUG; X 34;

ALZHEIMER DISEASE; AMYLOIDOSIS; AUTOPSY; BRAIN TISSUE; CELLULAR DISTRIBUTION; CHEMICAL LABELING; CHEMICAL STRUCTURE; CLINICAL PROTOCOL; DIAGNOSTIC ACCURACY; EXPERIMENTAL MOUSE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MUTATION; NEUROPATHOLOGY; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN DEFECT; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; REVIEW; SYNTHESIS; TISSUE DISTRIBUTION;

ALKENES; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; BENZOATES; DISEASE PROGRESSION; FLUORESCENT DYES; HISTOCYTOCHEMISTRY; HUMANS; NEUROFIBRILLARY TANGLES; SENILE PLAQUES;

EID: 33749607070     PISSN: 00766879     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0076-6879(06)12009-1     Document Type: Review

References (35)

1. Barden H. The presence of ethylenic bonds and vic-glycol groups in neuromelanin and lipofuscin in the human brain. J. Histochem. Cytochem. 31 (1983) 849-858
2. Barden H. The oxidative generation of sulfonic acid groups in neuromelanin and lipofuscin in the human brain. J. Histochem. Cytochem. 32 (1984) 329-336
3. Bennett D.A., Wilson R.S., Schneider J.A., Evans D.A., Beckett L.A., Aggarwal N.T., Barnes L.L., Fox J.H., and Bach J. Natural history of mild cognitive impairment in older persons. Neurology 59 (2002) 198-205
4. Bennhold H. Specific staining of amyloid by Congo red. Munchen Med. Wochnschr. 69 (1922) 1537-1538
5. Braak H., and Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 82 (1991) 239-259
6. Buxbaum J.N. The systemic amyloidoses. Curr. Opin. Rheumatol. 16 (2004) 67-75
7. DeKosky S.T., Ikonomovic M.D., Styren S.D., Beckett L., Wisniewski S., Bennett D.A., Cochran E.J., Kordower J.H., and Mufson E.J. Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment. Ann. Neurol. 51 (2002) 145-155
8. DeKosky S.T., Ikonomovic M.D., Hamilton R.L., Bennett D.A., and Mufson E.J. Neuropathology of mild cognitive impairment in the elderly. In: Gauthier S., Scheltens P., and Cummings J.L. (Eds). "Alzheimer's Disease and Related Disorders Annual," Vol. 5 (2005), Martin Dunitz & Parthenon Publishing, London 1-16
9. Desai P.P., Ikonomovic M.D., Abrahamson E.E., Hamilton R.L., Isanski B.A., Hope C.E., Klunk W.E., DeKosky S.T., and Kamboh M.I. Apolipoprotein D is a component of compact but not diffuse amyloid-beta plaques in Alzheimer's disease temporal cortex. Neurobiol. Dis. 20 (2005) 574-582
10. Dickson D.W. Required techniques and useful molecular markers in the neuropathological diagnosis of neurodegenerative disorders. Acta Neuropath. 109 (2005) 14-24
11. Dickson D.W. The pathogenesis of senile plaques. J. Neuropathol. Exp. Neurol. 56 (1997) 321-339
12. Dishino D.D., Welch M.J., Kilbourn M.R., and Raichle M.E. Relationship between lipophilicity and brain extraction of C-11-labeled radiopharmaceuticals. J. Nucl. Med. 24 (1983) 1030-1038
13. Ghoshal N., Garcia-Sierra F., Wuu J., Leurgans S., Bennett D.A., Berry R.W., and Binder L.I. Tau conformational changes correspond to impairments of episodic memory in mild cognitive impairment and Alzheimer's disease. Exp. Neurol. 177 (2002) 475-493
14. Guntern R., Vallet P.G., Bouras C., and Constantinidis J. An improved immunohistostaining procedure for peptides in human brain. Experientia 45 (1989) 159-161
15. Guntern R., Bouras C., Hof P.R., and Vallet P.G. An improved thioflavine S method for staining neurofibrillary tangles and senile plaques in Alzheimer's disease. Experientia 48 (1992) 8-10
16. Holcomb L., Gordon M.N., McGowan E., Yu X., Benkovic S., Jantzen P., Wright K., Saad I., Mueller R., Morgan D., Sanders S., Zehr C., O'Campo K., Hardy J., Prada C.M., Eckman C., Younkin S., Hsiao K., and Duff K. Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes. Nat. Med. 4 (1998) 97-100
17. Ikonomovic M.D., Uryu K., Abrahamson E.E., Ciallella J.R., Trojanowski J.Q., Lee V.MY., Clark R.S., Marion D.W., Wisniewski S.R., and DeKosky S.T. Alzheimer's pathology in human temporal cortex surgically excised after severe brain injury. Exp. Neurol. 190 (2004) 192-203
18. Ikonomovic M.D., Mufson E.J., Wuu J., Bennett D.A., and DeKosky S.T. Reduction of choline acetyltransferase activity in primary visual cortex in mild-moderate Alzheimer's disease. Arch. Neurol. 62 (2005) 425-430
19. Klunk W.E., Engler H., Nordberg A., Wang Y., Blomqvist G., Holt D.P., Bergstrom M., Savitcheva I., Huang G.F., Estrada S., Ausen B., Debnath M.L., Barletta J., Price J.C., Sandell J., Lopresti B.J., Wall A., Koivisto P., Antoni G., Mathis C.A., and Langstrom B. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Ann. Neurol. 55 (2004) 306-319
20. Kordower J.H., Chu Y., Stebbins G.T., DeKosky S.T., Cochran E.J., Bennett D., and Mufson E.J. Loss and atrophy of layer II entorhinal cortex neurons in elderly people with mild cognitive impairment. Ann. Neurol. 49 (2001) 202-213
21. Lopez O.L., Becker J.T., Klunk W., Saxton J., Hamilton R.L., Kaufer D.I., Sweet R.A., Cidis Meltzer C., Wisniewski S., Kamboh M.I., and DeKosky S.T. Research evaluation and diagnosis of probable Alzheimer's disease over the last two decades: I. Neurology 55 (2000) 1854-1862
22. Mathis C.A., Klunk W.E., Price J.C., and DeKosky S.T. Imaging technology for neurodegenerative diseases. Arch. Neurol. 62 (2005) 196-200
23. Mathis C.A., Wang Y., and Klunk W.E. Imaging beta-amyloid plaques and neurofibrillary tangles in the aging human brain. Curr. Pharm. Des. 10 (2004) 1469-1492
24. Mitchell T.W., Mufson E.J., Schneider J.A., Cochran E.J., Nissanov J., Han L.Y., Bienias J.L., Lee V.M., Trojanowski J.Q., Bennett D.A., and Arnold S.E. Parahippocampal tau pathology in healthy aging, mild cognitive impairment, and early Alzheimer's disease. Ann. Neurol. 51 (2002) 182-189
25. Mufson E.J., Chen E.Y., Cochran E.J., Beckett L.A., Bennett D.A., and Kordower J.H. Entorhinal cortex beta-amyloid load in individuals with mild cognitive impairment. Exp. Neurol. 158 (1999) 469-490
26. Mufson E.J., Ma S.Y., Cochran E.J., Bennett D.A., Beckett L.A., Jaffar S., Saragovi H.U., and Kordower J.H. Loss of nucleus basalis neurons containing trkA immunoreactivity in individuals with mild cognitive impairment and early Alzheimer's disease. J. Comp. Neurol. 427 (2000) 19-30
27. National Institute on Aging and Reagan Institute working group on diagnosis criteria for the neuropathological assessment of Alzheimer's disease. Consensus recommendations for the postmortem diagnosis of AD. Neurobiol. Aging 18 (1997) S1-S3
28. Oddo S., Caccamo A., Shepherd J.D., Murphy M.P., Golde T.E., Kayed R., Metherate R., Mattson M.P., Akbari Y., and LaFerla F.M. Triple-transgenic model of Alzheimer's disease with plaques and tangles: Intracellular Abeta and synaptic dysfunction. Neuron 39 (2003) 409-421
29. Price J.L., Davis P.B., Morris J.C., and White D.L. The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer's disease. Neurobiol. Aging 12 (1991) 295-312
30. Price J.L., and Morris J.C. Tangles and plaques in nondemented aging and "preclinical" Alzheimer's disease. Ann. Neurol. 45 (1999) 358-368
31. Puchtler H., Sweat F., and Levine M. On the binding of Congo red by amyloid. J. Histochem. Cytochem. 10 (1962) 355-364
32. Selkoe D.J. Folding proteins in fatal ways. Nature 426 (2003) 900-904
33. Sturchler-Pierrat C., Abramowski D., Duke M., Wiederhold K.H., Mistl C., Rothacher S., Ledermann B., Burki K., Frey P., Paganetti P.A., Waridel C., Calhoun M.E., Jucker M., Probst A., Staufenbiel M., and Sommer B. Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology. Proc. Natl. Acad. Sci. USA 94 (1997) 13287-13292
34. Styren S.D., Hamilton R.L., Styren G.C., and Klunk W.E. X-34, a fluorescent derivative of Congo red: A novel histochemical stain for Alzheimer's disease pathology. J. Histochem. Cytochem. 48 (2000) 1223-1232
35. Vallet P.G., Guntern R., Hof P.R., Golaz J., Delacourte A., Robakis N.K., and Bouras C. A comparative study of histological and immunohistochemical methods for neurofibrillary tangles and senile plaques in Alzheimer's disease. Acta Neuropathol. (Berl). 83 (1992) 170-178